SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007404
Filing Date
2022-05-04
Accepted
2022-05-04 16:28:47
Documents
48
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kura-20220331.htm   iXBRL 10-Q 2067465
2 EX-31.1 kura-ex31_1.htm EX-31.1 13466
3 EX-32.1 kura-ex32_1.htm EX-32.1 11356
  Complete submission text file 0000950170-22-007404.txt   6288138

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kura-20220331_pre.xml EX-101.PRE 185799
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kura-20220331_def.xml EX-101.DEF 86796
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kura-20220331_cal.xml EX-101.CAL 40213
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kura-20220331_lab.xml EX-101.LAB 276972
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kura-20220331.xsd EX-101.SCH 28420
42 EXTRACTED XBRL INSTANCE DOCUMENT kura-20220331_htm.xml XML 1190368
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37620 | Film No.: 22891973
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences